Teva Paid $300M Kickbacks Through Copay Groups, Feds Say

By Brian Dowling · August 18, 2020, 2:27 PM EDT

Teva Pharmaceuticals USA Inc. used two copay foundations to funnel more than $300 million in illegal kickbacks to Medicare patients using its multiple sclerosis drug, effectively subsidizing the treatment while steadily...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

UNITED STATES OF AMERICA v. TEVA PHARMACEUTICALS USA, INC. et al

Case Number

Court

Massachusetts

Nature of Suit

Other Statutes: False Claims Act

Date Filed

August 18, 2020

Recent Articles By Brian

November 15, 2024
Pharma Biz To Pay $47M To Settle Feds' Kickback Claims
October 15, 2024
Feds Cut Whistleblowers Out Of Kickback Deal, Court Told
October 09, 2024
Lead Test Maker Vows Compliance As $42M Deal Approved
October 07, 2024
Trio Of 1st Circ. Criminal Cases Turned Away By Top Court
October 02, 2024
Abortion Clinic To Get Early Discovery In Patient Spying Case
October 01, 2024
Mass. Hospital To Pay Up To $6.5M In Sober Home Scheme
September 30, 2024
Medical Device Co. Wins $25M Verdict In Poaching Trial
September 26, 2024
Behavioral Health Exec Pleads Guilty To Medical Billing Fraud
September 03, 2024
Aesthetic Laser Co. Tells Jury Of Rival's 'Corporate Raid'
July 31, 2024
1st Circ. Mostly Backs $5M Award In Biotech Recruiting Spat